Increased functional potency of multi-edited CAR-T cells manufactured by a non-viraltransfection system.
Find out more about a novel non-viral delivery method that enables efficient engineering of primary human T cells for ex vivo cell therapy applications.
Find out more about our Vector-free intracellular delivery by reversible permeabilization.